Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy

Radiotherapy and Oncology

Volumn 83, Issue 3, 2007, Pages 249-255

  Dewhirst, Mark W ^a   Cao, Yiting ^a   Li, Chuan Yuan ^b   Moeller, Benjamin ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; HIF 1; Hypoxia; Radiotherapy response

Indexed keywords

ANGIOGENESIS INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1; REACTIVE OXYGEN METABOLITE; TIRAPAZAMINE;

ANGIOGENESIS; CANCER RADIOTHERAPY; CHEMOTAXIS; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; REOXYGENATION; REVIEW; TUMOR GROWTH;

ANOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NEOVASCULARIZATION, PATHOLOGIC; RADIOTHERAPY;

EID: 34250219672     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.05.016     Document Type: Review

References (21)

1. Oltean S., Sorg B.S., Albrecht T., et al. Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity. Proc Natl Acad Sci USA 103 (2006) 14116-14121
2. Yin J.Q., Gao J., Shao R., et al. siRNA agents inhibit oncogene expression and attenuate human tumor cell growth. J Exp Ther Oncol 3 (2003) 194-204
3. Dewhirst M.W., Shan S., Cao Y., et al. Intravital fluorescence facilitates measurement of multiple physiologic functions and gene expression in tumors of live animals. Dis Markers 18 (2002) 293-311
4. Li C.Y., Shan S., Huang Q., et al. Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. J Natl Cancer Inst 92 (2000) 143-147
5. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 (2003) 721-732
6. Cao Y., Li C.Y., Moeller B.J., et al. Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation. Cancer Res 65 (2005) 5498-5505
7. Sorg B.S., Moeller B.J., Donovan O., et al. Hyperspectral imaging of hemoglobin saturation in tumor microvasculature and tumor hypoxia development. J Biomed Opt 10 (2005) 44004
8. Moeller B.J., Cao Y., Li C.Y., et al. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5 (2004) 429-441
9. Moeller B.J., Batinic-Haberle I., Spasojevic I., et al. A manganese porphyrin superoxide dismutase mimetic enhances tumor radioresponsiveness. Int J Radiat Oncol Biol Phys 63 (2005) 545-552
10. Quintero M., Brennan P.A., Thomas G.J., et al. Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: role of free radical formation. Cancer Res 66 (2006) 770-774
11. Hess D.T., Matsumoto A., Kim S.O., et al. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 6 (2005) 150-166
12. Berchner-Pfannschmidt U., Yamac H., Trinidad B., et al. Nitric oxide modulates oxygen sensing by hypoxia-inducible factor 1-dependent induction of prolyl hydroxylase 2. J Biol Chem 282 (2007) 1788-1796
13. Li F., Sonveaux P., Rabbani Z.N., et al. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell 26 (2007) 63-74
14. Moeller B.J., Dreher M.R., Rabbani Z.N., et al. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 8 (2005) 99-110
15. Gorski D.H., Beckett M.A., Jaskowiak N.T., et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59 (1999) 3374-3378
16. Cao Y., Linden P., Shima D., et al. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J Clin Invest 98 (1996) 2507-2511
17. Pore N., Gupta A.K., Cerniglia G.J., et al. Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy. Cancer Res 66 (2006) 9252-9259
18. Sasabe E., Zhou X., Li D., et al. The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells. Int J Cancer 120 (2007) 268-277
19. Williams K.J., Telfer B.A., Xenaki D., et al. Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1. Radiother Oncol 75 (2005) 89-98
20. Vujaskovic Z., Batinic-Haberle I., Rabbani Z.N., et al. A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury. Free Radic Biol Med 33 (2002) 857-863
21. Rabbani Z.N., Batinic-Haberle I., Anscher M.S., et al. Long-term administration of a small molecular weight catalytic metalloporphyrin antioxidant, AEOL 10150, protects lungs from radiation-induced injury. Int J Radiat Oncol Biol Phys 67 (2007) 573-580